Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer
Gynecol Oncol, 192, 80-88 (in press)
DOI 10.1016/j.ygyno.2024.11.005, PubMed 39549540
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting
Int J Gynecol Cancer, 34 (11), 1677-1684
DOI 10.1136/ijgc-2024-005982, PubMed 39496422
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial
J Gynecol Oncol, 35 (6), e117
DOI 10.3802/jgo.2024.35.e117, PubMed 39453395